Pet Cancer Therapeutics Market on the Rise: 2024 Research Report Shows Extensive Growth and Technological Advancements - Long-term Forecast to 2028 and 2033
January 30, 2024 10:44 ET
|
Research and Markets
Dublin, Jan. 30, 2024 (GLOBE NEWSWIRE) -- The "Pet Cancer Therapeutics Global Market Report 2024" report has been added to ResearchAndMarkets.com's offering. The global pet cancer therapeutics...
Worldwide Pet Cancer Therapeutics Industry to 2027: Increasing Awareness Regarding Pet Healthcare and Treatments Drives Growth
February 24, 2023 07:23 ET
|
Research and Markets
Dublin, Feb. 24, 2023 (GLOBE NEWSWIRE) -- The "Pet Cancer Therapeutics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2017-2027 Segmented By Therapy (Surgery, Radiotherapy,...
PetCure Oncology Announces Capital Raise with Plans for Public Offering, Expansion of Pet Cancer Network
July 17, 2019 09:00 ET
|
PetCure Oncology
Deerfield, IL, July 17, 2019 (GLOBE NEWSWIRE) -- PetCure Oncology, LLC, a company providing veterinary cancer treatment utilizing non-surgical stereotactic radiosurgery (SRS) and stereotactic...
Vivos Inc. Reports Strong Reception to IsoPet® At Veterinary Cancer Society Conference
October 22, 2018 07:00 ET
|
Vivos Inc.
Richland WA, Oct. 22, 2018 (GLOBE NEWSWIRE) -- Vivos, Inc. (OTC PINK: RDGL) Vivos Inc is pleased to report that its attendance and presentation at the annual meeting of the Veterinary Cancer Society...